Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 69459 

U.S. Department of Justice, Office of 

Justice Programs, National Institute of 

Justice (NIJ) will make available to the 

general public the draft ‘‘NIJ Law 

Enforcement Duty Holster Selection and 

Application Guide.’’ The opportunity to 

provide comments on this document is 

open to industry technical 

representatives, law enforcement 

agencies and organizations, research, 

development and scientific 

communities, and all other stakeholders 

and interested parties. Those 

individuals wishing to obtain and 

provide comments on the draft 

document under consideration are 

directed to the following Web site: 

http://www.justnet.org. 

DATES: Comments must be received on 

or before December 13, 2010. 

FOR FURTHER INFORMATION CONTACT: 

Vanessa Castellanos, by telephone at 

202–514–5272 [Note: This is not a tollfree telephone number], or by e-mail at 

vanessa.castellanos@usdoj.gov. 

John H. Laub, 

Director, National Institute of Justice. 

[FR Doc. 2010–28431 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–18–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on August 

26, 2010, Formulation Technologies 

LLC., 11400 Burnet Road, Suite 4010, 

Austin, Texas 78758, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Fentanyl (9801), a basic 

class of controlled substance listed in 

schedule II. 

The company plans to import the 

listed controlled substance for analytical 

characterization, secondary packaging, 

and for distribution to clinical trial sites. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration, 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such comments or objections 

being sent via regular mail should be 

addressed, in quintuplicate, to the Drug 

Enforcement Administration, Office of 

Diversion Control, Federal Register 

Representative (ODL), 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

must be filed no later than December 13, 

2010. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substances in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28527 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to Title 21 Code of Federal 

Regulations 1301.34 (a), this is notice 

that on June 16, 2010, Cerilliant 

Corporation, 811 Paloma Drive, Suite A, 

Round Rock, Texas 78665–2402, made 

application by renewal to the Drug 

Enforcement Administration (DEA) for 

registration as an importer of the basic 

classes of controlled substances listed in 

schedule I and II: 

Drug Schedule 

Cathinone (1235) ......................................................................................................................................................................................... I 

Methcathinone (1237) .................................................................................................................................................................................. I 

N–Ethylamphetamine (1475) ....................................................................................................................................................................... I 

N,N–Dimethylamphetamine (1480) ............................................................................................................................................................. I 

Fenethylline (1503) ...................................................................................................................................................................................... I 

Gamma Hydroxybutyric Acid (2010) ........................................................................................................................................................... I 

Ibogaine (7260) ........................................................................................................................................................................................... I 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... I 

Marihuana (7360) ........................................................................................................................................................................................ I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) ......................................................................................................................................................................................... I 

3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ I 

4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 

3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I 

3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I 

3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) ................................................................................................................................................................... I 

Diethyltryptamine (7434) ............................................................................................................................................................................. I 

Dimethyltryptamine (7435) .......................................................................................................................................................................... I 

Psilocybin (7437) ......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................ I 

mstockstill on DSKH9S0YB1PROD with NOTICES

69460 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 

Drug Schedule 

5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. I 

N-Benzylpiperazine (7493) .......................................................................................................................................................................... I 

Etorphine (except HCl) (9056) .................................................................................................................................................................... I 

Heroin (9200) ............................................................................................................................................................................................... I 

Morphine-N-oxide (9307) ............................................................................................................................................................................. I 

Normorphine (9313) .................................................................................................................................................................................... I 

Pholcodine (9314) ....................................................................................................................................................................................... I 

Dextromoramide (9613) ............................................................................................................................................................................... I 

Dipipanone (9622) ....................................................................................................................................................................................... I 

Racemoramide (9645) ................................................................................................................................................................................. I 

Trimeperidine (9646) ................................................................................................................................................................................... I 

Tilidine (9750) .............................................................................................................................................................................................. I 

Amphetamine (1100) ................................................................................................................................................................................... II 

Methamphetamine (1105) ........................................................................................................................................................................... II 

Methylphenidate (1724) ............................................................................................................................................................................... II 

Amobarbital (2125) ...................................................................................................................................................................................... II 

Pentobarbital (2270) .................................................................................................................................................................................... II 

Secobarbital (2315) ..................................................................................................................................................................................... II 

Phencyclidine (7471) ................................................................................................................................................................................... II 

Phenylacetone (8501) ................................................................................................................................................................................. II 

Cocaine (9041) ............................................................................................................................................................................................ II 

Codeine (9050) ............................................................................................................................................................................................ II 

Dihydrocodeine (9120) ................................................................................................................................................................................ II 

Oxycodone (9143) ....................................................................................................................................................................................... II 

Hydromorphone (9150) ............................................................................................................................................................................... II 

Benzoylecgonine (9180) .............................................................................................................................................................................. II 

Ethylmorphine (9190) .................................................................................................................................................................................. II 

Meperidine (9230) ....................................................................................................................................................................................... II 

Methadone (9250) ....................................................................................................................................................................................... II 

Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. II 

Morphine (9300) .......................................................................................................................................................................................... II 

Oripavine (9330) .......................................................................................................................................................................................... II 

Thebaine (9333) .......................................................................................................................................................................................... II 

Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II 

Oxymorphone (9652) ................................................................................................................................................................................... II 

Poppy Straw Concentrate (9670) ................................................................................................................................................................ II 

Fentanyl (9801).

The company plans to import small 

quantities of the listed controlled 

substances for the manufacture of 

analytical reference standards. 

No comments, objections, or requests 

for any hearings will be accepted on any 

application for registration or reregistration to import crude opium, 

poppy straw, concentrate of poppy 

straw, and coca leaves. As explained in 

the Correction to Notice of Application 

pertaining to Rhodes Technologies, 72 

FR 3417 (2007), comments and requests 

for hearings on applications to import 

narcotic raw material are not 

appropriate. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic classes of controlled 

substances listed in schedule I or II, 

which fall under the authority of section 

1002(a)(2)(B) of the Act [(21 U.S.C. 952 

(a)(2)(B)] may, in the circumstances set 

forth in 21 U.S.C. 958(i), file comments 

or objections to the issuance of the 

proposed registration and may, at the 

same time, file a written request for a 

hearing on such application pursuant to 

21 CFR § 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than December 13, 2010. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substances in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28519 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on 

September 14, 2010, GE Healthcare, 

3350 North Ridge Avenue, Arlington 

mstockstill on DSKH9S0YB1PROD with NOTICES